Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Randomized, Double-blind, Double-dummy, Placebo-controlled, Crossover Study to Evaluate the Efficacy of TREXIMET® (Sumatriptan + Naproxen Sodium) vs. Butalbital-containing Combination Medications for the Acute Treatment of Migraine when administered during the Moderate-Severe Migraine Pain, 1 of 2
sumatriptan/naproxen
TRX109011
NCT01812408
Migraine Disorders
Phase 3
 
The results of this study have been pooled with study TRX109013 and summarised on the GSK Clinical Study Register.
May 2013

Powered by ideaPoint, Inc.